Comparison between technetium-99m methoxyisobutylisonitrile scintigraphy and ultrasound in the diagnosis of parathyroid adenoma and parathyroid hyperplasia.
Jianjun Xue,Yan Liu,Ting Ji,Aomei Zhao,Yiqian Liang,Huixing Deng,Qi Wang,Yuemin Zhang,Lulu Yang,Aimin Yang
DOI: https://doi.org/10.1097/MNM.0000000000000921
2018-01-01
Nuclear Medicine Communications
Abstract:Objective The aim of this study was to evaluate the value of technetium-99m methoxyisobutylisonitrile (Tc-99m-MIBI) imaging and ultrasound in preoperative localization of parathyroid adenoma (PA) and parathyroid hyperplasia (PH). Participants and methods A retrospective study of Tc-99m-MIBI double-phase scintigraphy (DPS) was performed in 187 hyperparathyroidism cases with pathologically diagnosed PA or PH. Of these patients, 167 cases underwent ultrasound, and 146 cases underwent Tc-99m-MIBI single-photon emission computed tomography/computed tomography (SPECT/CT). The sensitivity and diagnostic accuracy of ultrasound, Tc-99m-MIBI DPS, and SPECT/CT were compared between PA and PH. Differences in Tc-99m-MIBI DPS, serum parathyroid hormone (PTH), serum calcium and phosphorus, as well as the weight and longest diameter of lesion between PA and PH were also compared. Results As per patient-based analysis, the sensitivity of ultrasound, Tc-99m-MIBI DPS, and SPECT/CT was 90.70% (39/43), 95.56% (43/45), and 100.00% (30/30), respectively, for PA, and 93.55% (116/124), 90.85% (129/142), and 93.10% (108/116), respectively, for PH. There were no significant differences in sensitivity of these three imaging methods between PA and PH. However, per lesion-based analysis, the accuracy of ultrasound, Tc-99m-MIBI DPS, and SPECT/CT in detecting PA was 78.43% (40/51), 86.79% (46/53) and 96.88% (31/32), respectively, and the accuracy of Tc-99m-MIBI DPS was higher than that of ultrasound (chi(2)=6.507, P=0.011), and for PH, it was 49.69% (160/322), 40.71% (171/420), and 43.80% (152/347), respectively. The accuracy of ultrasound was higher than that of Tc-99m-MIBI DPS (chi(2)=5.940, P=0.015). The accuracy of a combination of all three examinations of ultrasound+Tc-99m-MIBI DPS, ultrasound+Tc-99m-MIBI SPECT/CT, Tc-99m-MIBI DPS+SPECT/CT, and ultrasound+Tc-99m-MIBI DPS+Tc-99m-MIBI SPECT/CT was 51.51% (154/299), 53.85% (161/299), 50.17% (150/299), and 54.18% (162/299), respectively, which was higher than that of ultrasound (chi(2)=5.273, P=0.022; chi(2)=8.226, P=0.004; chi(2)=3.880, P=0.049; chi(2)=8.702, P=0.003, respectively). Serum levels of PTH and phosphorus were lower in patients with PA than in patients with PH (P<0.001), and serum calcium level, the weight, and the longest diameter of lesion and early uptake rate of Tc-99m-MIBI DPS were higher in patients with PA than in patients with PH (P<0.01). Serum PTH level is often less than 1000 pg/ml in PA, but usually more than 1000 pg/ml in PH. Conclusion Ultrasound, Tc-99m-MIBI DPS, and SPECT/CT all have a higher value in the diagnosis of PA than PH. Tc-99m-MIBI SPECT/CT should be optimal for detecting PA, and early SPECT/CT scan might be better than delayed scan. Compared with Tc-99m-MIBI DPS and SPECT/CT, ultrasound has a slight advantage in localization of PH lesions. The combination of ultrasound and Tc-99m-MIBI DPS or SPECT/CT imaging could improve the accuracy in localization of PH lesions and should be considered as the first-line method for detecting PH.